Targeting Adenosine A2b Receptor Promotes Penile Rehabilitation of Refractory Erectile Dysfunction
Advanced Science · 2024-08 · 11 (30)
DOI: 10.1002/advs.202306514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.06.2024. Verfasst von Yang Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Andrology Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China. Hauptthemen laut MEDLINE: Disease Models, Animal, Erectile Dysfunction, Receptor, Adenosine A2B. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Sichuan Science and Technology Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
The mechanisms of adenosine and specific adenosine receptor subtypes in promoting penile rehabilitation remain unclear. Single‐cell RNA sequencing of human corpus cavernosum, adenosine deaminase (ADA) and adenosine receptors knock‐out mice (ADA −/− , A1 −/− , A2a −/− , A2b −/− , and A3 −/− ), and primary corpus cavernosum smooth muscle cells are used to determine receptor subtypes responsible for adenosine‐induced erection. Three rat models are established to characterize refractory erectile dysfunction (ED): age‐related ED, bilateral cavernous nerve crush related ED (BCNC), and diabetes mellitus‐induced ED. In single‐cell RNA sequencing data, the corpus cavernosum of ED patients show a decrease in adenosine A1, A2a and A2b receptors. In vivo, A2b receptor knock‐out abolishes adenosine‐induced erection but not that of A1, A2a, or A3 receptor. Under hypoxic conditions in vitro, activating the A2b receptor increases HIF‐1α and decreases PDE5 expression. In refractory ED models, activating the A2b receptor with Bay 60–6583 improves erectile function and down‐regulates HIF‐1α and TGF‐β. Administering Dipyridamole (40 mg Kg −1 ) to BCNC rats improve penile adenosine levels and erectile function. Our study reveals that the A2b receptor mediates adenosine‐induced penile erection. Activating the A2b receptor promotes penile rehabilitation of refractory ED by alleviating hypoxia and fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Andrology Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- Division of Urology, University of Texas Medical School at Houston, Houston, TX, 77030, USA.
ORCID-Profile: Jiuhong Yuan
Förderung
- Natural Science Foundation of China
- Sichuan Science and Technology Program
- National Natural Science Foundation of China
Zitieren
APA
Xiong, Y., Qin, F., Wei, S., Yang, X., Li, J., Wu, C., Zhang, F., & Yuan, J. (2024). Targeting Adenosine A2b Receptor Promotes Penile Rehabilitation of Refractory Erectile Dysfunction. Advanced Science, 11(30). https://doi.org/10.1002/advs.202306514
Vancouver
Xiong Y, Qin F, Wei S, Yang X, Li J, Wu C, et al. Targeting Adenosine A2b Receptor Promotes Penile Rehabilitation of Refractory Erectile Dysfunction. Advanced Science. 2024;11(30). doi:10.1002/advs.202306514
BibTeX
@article{Xiong2024,
author = {Xiong, Yang and Qin, Feng and Wei, Shanzun and Yang, Xingliang and Li, Jun and Wu, Changjing and Zhang, Fuxun and Yuan, Jiuhong},
title = {Targeting Adenosine A2b Receptor Promotes Penile Rehabilitation of Refractory Erectile Dysfunction},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {30},
doi = {10.1002/advs.202306514}
}
EUVIMED